BUDOCOL-TABLET

Description:

• BUDOCOL Tablet contains Budesonide Controlled Release (CR) 9 mg, a corticosteroid formulated for targeted delivery to the gastrointestinal tract. It is indicated for the treatment of mild to moderate ulcerative colitis and asthma, providing anti-inflammatory effects with minimal systemic absorption.
• Produced by reputed budesonide api manufacturers, this tablet guarantees high purity and controlled-release consistency.
• Our products are trusted by budesonide capsules dealers and distributed widely to meet the needs of healthcare providers.
• As leading anti asthma drug manufacturers, we specialize in formulating effective therapies with minimized side effects.
• Additionally, we are recognized as a reliable asthma tablets exporter, delivering quality medications globally with full compliance to regulatory standards.

Key Features:

• Controlled release formulation ensures colon-targeted delivery, enhancing efficacy in inflammatory bowel diseases.
• Budesonide CR offers potent local anti-inflammatory action with reduced systemic side effects compared to conventional corticosteroids.
• Effective in inducing remission in ulcerative colitis and managing asthma symptoms.
• Once-daily dosing improves patient compliance and convenience.
• Demonstrated efficacy in clinical studies for gastrointestinal and respiratory inflammatory conditions.

Usage Guidelines:

• Administer orally as directed by a healthcare professional, typically one tablet once daily in the morning.
• Swallow the tablet whole; do not crush or chew to maintain the controlled release mechanism.
• Dosage and duration of therapy should be individualized based on patient response and clinical condition.

Safety Profile:

• Generally well-tolerated; potential side effects may include headache, nausea, abdominal pain, and fatigue.
• Use with caution in patients with hepatic impairment; monitor for signs of systemic corticosteroid effects.
• Avoid concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, grapefruit juice) as they may increase systemic exposure.
• Not recommended for patients with known hypersensitivity to budesonide or any component of the formulation.
• Consult a healthcare provider before use during pregnancy or lactation.

Uses / Indications:  Used in the treatment of asthma and Ulcerative colitis